论文部分内容阅读
目的与方法⑶采用经周围静脉注射手振氟碳微泡彩色多普勒增强造影检查了 ３５ 例肝肿瘤及 １８ 例正常肝脏患者⒙以探讨肝肿瘤彩色多普勒增强造影方面的特征表现⒚结果⑶动脉相 ２０ 例 ⒉９０９ ％ ⒕原发性肝癌及 ２ 例⒉３３３％ ⒕转移性肝癌肿瘤内彩色血流增强程度强于周围肝组织⒙２ 例 ⒉９１％ ⒕原发性肝癌及 ４ 例 ⒉６６７ ％ ⒕转移性肝癌弱于周围肝组织⒙所有肝血管瘤无瘤内彩色血流增强⒚１０ 例 ⒉４５５ ％ ⒕原发性肝癌门脉血流提前增强⒙所有转移性肝癌及肝血管瘤未见门脉血流提前增强⒚门脉相 ２１ 例 ⒉９５５％ ⒕原发性肝癌、４ 例 ⒉６ ６７％ ⒕转移性肝癌及 ２ 例⒉２８６ ％ ⒕肝血管瘤可见肿瘤内血流增强⒚结论⑶彩色多普勒增强造影对肝肿瘤诊断及治疗选择方面有重要的临床价值⒚
Objectives and methods (3) To detect 35 cases of liver tumors and 18 cases of normal livers by peripheral venous injection of fluorocarbon microbubbles with color Doppler contrast imaging.18. To investigate characteristics of liver tumors with color Doppler contrast angiography. 19. Results (3) 20 of arterial phase 2.909 % 14. Primary liver cancer and 2 cases of 2.333% 14. Color blood flow enhancement in metastatic liver cancer tumors was stronger than in peripheral liver tissues 18.2 cases 2.91% 14. Primary liver cancer and 4 Example 2.66 7 % 14. Metastatic liver cancer is weaker than surrounding liver tissue 18. All intrahepatic hemangiomas have no tumor color flow enhancement 19.10 2.45 5 % 14. Portal blood flow enhancement in primary liver cancer 18. All metastatic liver cancer and liver Hemangiomas did not see portal vein blood flow enhancement. 19. Portal vein phase 21 cases 2.95 5% 14. Primary liver cancer, 4 cases 2. 6 7% 14. Metastatic liver cancer and 2 cases 2.28 6% 14. Hepatic hemangioma visible tumor Intravascular enhancement 19. Conclusion (3) Color Doppler enhanced angiography has important clinical value in the diagnosis and treatment of liver tumors. 19.